Results 161 to 170 of about 73,182 (252)

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, Volume 38, Issue 61, 2 November 2026.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Coixenolide Enhances Antitumor Immunity of Cytotoxic CD8+ T Cells by Inhibiting S100A8/A9‐CD36 Axis in Obesity‐Associated Pancreatic Adenocarcinoma

open access: yesAdvanced Science, Volume 13, Issue 62, 9 November 2026.
Pancreatic adenocarcinoma (PAAD) remains highly lethal with limited treatment options. This study demonstrates that coixenolide, a bioactive compound from Coix lacryma‐jobi L. and a key component of the clinically approved Kanglaite injection, exhibits enhanced antitumor efficacy in high‐fat diet (HFD)‐induced obese mice bearing PAAD tumors compared to
Kaidi Chen   +20 more
wiley   +1 more source

Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review. [PDF]

open access: yesJ Hepatocell Carcinoma
Li J   +13 more
europepmc   +1 more source

Macrophage PABPC4‐SPP1 Axis Orchestrates Immunosuppression in Colorectal Cancer

open access: yesAdvanced Science, Volume 13, Issue 63, 12 November 2026.
In the CRC microenvironment, macrophage PABPC4 binds to the 3′UTR of SPP1 mRNA to stabilize its expression, thereby sustaining M2‐like immunosuppressive macrophage polarization. Concurrently, this axis suppresses CD8+ T cell effector functions via CD44 signaling, collectively fostering an immunosuppressive niche that drives tumor progression.
Meng Wang   +14 more
wiley   +1 more source

Identification of the Glycosaminoglycan Metabolism‐Related Protein IDUA Associated With Tumor Progression and Prognosis in ccRCC

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Objective This study investigated the expression, prognostic significance, and functional role of α‐L‐iduronidase (IDUA) in clear cell renal cell carcinoma (ccRCC). Methods We performed two‐sample Mendelian randomization using eQTL and ccRCC GWAS data. We analyzed transcriptomic and clinical data from TCGA and GEO cohorts.
Zhangjun Cao   +6 more
wiley   +1 more source

Composition of immune cells in peripheral blood of patients with leukemia in remission after stem cell transplantation (HSCT) with or without graft-versus-host disease (GvHD): a comparative analysis with healthy donors. [PDF]

open access: yesFront Immunol
Simon VM   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy